Nalazite se na CroRIS probnoj okolini. Ovdje evidentirani podaci neće biti pohranjeni u Informacijskom sustavu znanosti RH. Ako je ovo greška, CroRIS produkcijskoj okolini moguće je pristupi putem poveznice www.croris.hr
izvor podataka: crosbi !

Outcome domains and measures for pain in psoriasis used in registered trials: analysis of studies on ClinicalTrials.gov (CROSBI ID 299842)

Prilog u časopisu | izvorni znanstveni rad | međunarodna recenzija

Vucemilovic, Ana Sanader ; Puljak, Livia Outcome domains and measures for pain in psoriasis used in registered trials: analysis of studies on ClinicalTrials.gov // Journal of comparative effectiveness research, 10 (2021), 11; 909-915. doi: 10.2217/cer-2021-0012

Podaci o odgovornosti

Vucemilovic, Ana Sanader ; Puljak, Livia

engleski

Outcome domains and measures for pain in psoriasis used in registered trials: analysis of studies on ClinicalTrials.gov

Aim: Psoriasis includes unpleasant symptoms such as pain. This study aimed to investigate whether clinical trials have domains related to pain in their study designs. Materials and methods: We analyzed all clinical trials about interventions for psoriasis treatment registered on ClinicalTrials.gov and the frequency of pain- related outcomes. Results: Our analysis included 1033 registered clinical trials. They had 1329 primary outcomes and 5457 secondary outcomes. The pain was used in six (0.6%) protocols as a primary outcome and 68 (6.5%) protocols as a secondary outcome. Conclusion: Pain as an outcome was used in few registered clinical trial protocols for the treatment of psoriatic conditions. Future studies should investigate why the trialists do not include pain among primary or secondary outcomes.

psoriasis

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

Podaci o izdanju

10 (11)

2021.

909-915

objavljeno

2042-6305

10.2217/cer-2021-0012

Povezanost rada

Javno zdravstvo i zdravstvena zaštita

Poveznice
Indeksiranost